Search results for "Blood"

showing 10 items of 5199 documents

The relationship between age and production of tumour necrosis factor-α in healthy volunteers and patients with chronic heart failure

2003

Ageing is associated with an altered immune response. Elevated plasma levels of tumour necrosis factor-alpha (TNF-alpha) are present in patients with advanced chronic heart failure (CHF). However, the relationship between age and the immune response in CHF is unknown.We investigated the relationship between age and the TNF-alpha generating capacity of lipopolysaccharide (LPS) stimulated peripheral blood mononuclear cells (PBMC) in nine healthy control subjects (mean age 51.6+/-3.6 years, age range 39-75 years) and 22 stable patients with CHF (mean age 68.3+/-1.5 years, age range 52-78 years, NYHA class 3.0+/-0.2). We also tested the TNF-alpha generating capacity of all control subjects and …

AdultLipopolysaccharidesMalemedicine.medical_specialtyHeart diseaseEnzyme-Linked Immunosorbent AssayPeripheral blood mononuclear cellMonocytesImmune systemInternal medicinemedicineHumansAgedWhole bloodHeart FailureAnalysis of VarianceTumor Necrosis Factor-alphabusiness.industryAge FactorsGestational ageMiddle Agedmedicine.diseaseLogistic ModelsEndocrinologyAgeingCase-Control StudiesHeart failureChronic DiseaseImmunologyFemaleTumor necrosis factor alphaCardiology and Cardiovascular MedicinebusinessBiomarkersInternational Journal of Cardiology
researchProduct

Effect of noradrenaline and isoproterenol on lipopolysaccharide-induced tumor necrosis factor-alpha production in whole blood from patients with chro…

2005

Increased levels of tumor necrosis factor-alpha (TNF-alpha) correlate with poor prognoses in chronic heart failure (CHF). This study demonstrated that noradrenaline and isoproterenol inhibit TNF-alpha production in patients with CHF in ex vivo whole blood in a dose-dependent fashion. The beta-blocker bisoprolol abolishes this effect.

AdultLipopolysaccharidesMalemedicine.medical_specialtyLipopolysaccharideAdrenergic receptorAdrenergic beta-AntagonistsNorepinephrinechemistry.chemical_compoundInternal medicineReceptors Adrenergic betamedicineBisoprololHumansReceptorWhole bloodHeart FailureTumor Necrosis Factor-alphabusiness.industryIsoproterenolCardiovascular Agentsmedicine.diseaseEndocrinologychemistryBisoprololHeart failurecardiovascular systemCardiologyFemaleTumor necrosis factor alphaCardiology and Cardiovascular MedicinebusinessEx vivomedicine.drugThe American Journal of Cardiology
researchProduct

Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C

2010

UNLABELLED 25-Hydroxyvitamin D (25[OH]D) can potentially interfere with inflammatory response and fibrogenesis. Its role in disease progression in chronic hepatitis C (CHC) and its relation with histological and sustained virological response (SVR) to therapy are unknown. One hundred ninety-seven patients with biopsy-proven genotype 1 (G1) CHC and 49 healthy subjects matched by age and sex were consecutively evaluated. One hundred sixty-seven patients underwent antiviral therapy with pegylated interferon plus ribavirin. The 25(OH)D serum levels were measured by high-pressure liquid chromatography. Tissue expression of cytochrome (CY) P27A1 and CYP2R1, liver 25-hydroxylating enzymes, were as…

AdultLiver CirrhosisMaleVITAMIN D CHRONIC HEPATITIS Cmedicine.medical_specialtyGenotypeCombination therapyHepacivirusSettore MED/08 - Anatomia PatologicaGastroenterologychemistry.chemical_compoundBlood serumRisk FactorsPegylated interferonInternal medicineRibavirinmedicineVitamin D and neurologyHumansVitamin DCytochrome P450 Family 2AgedSettore MED/12 - GastroenterologiaHepatologybusiness.industryRibavirinHepatitis CHepatitis C ChronicMiddle Agedmedicine.diseasechemistryImmunologyCholestanetriol 26-MonooxygenaseFemaleInterferonsSteatosisbusinessViral hepatitismedicine.drug
researchProduct

Assessment of blood coagulation in severe liver disease using thromboelastography: use of citrate storage versus native blood.

2003

Thromboelastography evaluates the viscoelastic properties of blood coagulation. Using native blood, measurement must start soon after sampling. With normal coagulation, native and citrated blood values correlate well. No data exists from cirrhotic patients. We compared native and citrate thromboelastography parameters in 30 cirrhotic patients (20 Child-Pugh C class, two liver failure). Thromboelastography was performed within 4 min using native blood and after recalcification within 1-2 h of citrate storage. Thromboelastography variables (r, a, k, ma) were compared using the Mann-Whitney test, correlation investigated with the Pearson method and the degree of agreement with the Bland-Altman…

AdultLiver CirrhosisMalemedicine.medical_specialtyCirrhosisTime FactorsInsuficiencia hepaticaGastroenterologyLiver diseaseInternal medicinemedicineHumansCitratesBlood CoagulationAgedHepatitis Chronicmedicine.diagnostic_testbusiness.industryLiver DiseasesSignificant differenceLiver failureHematologyGeneral MedicineMiddle Agedmedicine.diseaseThromboelastographySurgeryThrombelastographyCoagulationFemaleBlood Coagulation TestsbusinessLiver FailureBlood coagulationfibrinolysis : an international journal in haemostasis and thrombosis
researchProduct

Parallel reduction of plasma levels of high and low molecular weight kininogen in patients with cirrhosis

1999

SummaryLittle is known about the regulation of high-molecular-weight-kininogen (HK) and low-molecular-weight-kininogen (LK) or the relationship of each to the degree of liver function impairment in patients with cirrhosis. In this study, we evaluated HK and LK quantitatively by a recently described particle concentration fluorescence immunoassay (PCFIA) and qualitatively by SDS PAGE and immunoblotting analyses in plasma from 33 patients with cirrhosis presenting various degrees of impairment of liver function. Thirty-three healthy subjects served as normal controls. Patients with cirrhosis had significantly lower plasma levels of HK (median 49 μg/ml [range 22-99 μg/ml]) and LK (58 μg/ml [15…

AdultLiver CirrhosisMalemedicine.medical_specialtyPathologyKininogen High-Molecular-WeightCirrhosisHigh-molecular-weight kininogenKininogen Low-Molecular-WeightSeverity of Illness IndexLiver diseaseLiver Function TestsInternal medicineBlood plasmaCholinesterasesHumansMedicineSerum AlbuminAgedKininogenbusiness.industryAlbuminHematologyBlood Coagulation DisordersMiddle Agedmedicine.diseaseLow-molecular-weight kininogenEndocrinologyProthrombin TimeFemaleLiver functionbusiness
researchProduct

Increased interleukin 6 production by bronchoalveolar lavage cells in patients with active sarcoidosis

1993

Alveolitis of sarcoidosis is characterized by activated alveolar macrophages (AMs) and T cells. The mediators interleukin-1 (IL-1) and interleukin 6 (IL-6) released by AMs represent essential factors for the progression of the T cells in the cell cycle. The role of IL-1 in pulmonary sarcoidosis has previously been studied; however, the relevance of other mediators (i.e. IL-6) has not yet been evaluated. We measured the spontaneous and lipopolysaccharide (LPS)-induced release of IL-6 and tumor necrosis factor alpha (TNF alpha) by bronchoalveolar lavage cells (BAL) and peripheral blood mononuclear cells (PBMNC) in 6 control subjects (group A) and in 15 patients with sarcoidosis, 10 with activ…

AdultLung DiseasesMalePulmonary and Respiratory Medicinemedicine.medical_specialtySarcoidosisLipopolysaccharidePeripheral blood mononuclear cellchemistry.chemical_compoundInternal medicineHumansMedicineInterleukin 6AgedLungmedicine.diagnostic_testbiologyInterleukin-6Tumor Necrosis Factor-alphabusiness.industryMiddle AgedCell cyclemedicine.diseaseBronchoalveolar lavageEndocrinologymedicine.anatomical_structurechemistryImmunologybiology.proteinFemaleTumor necrosis factor alphaSarcoidosisbusinessBronchoalveolar Lavage FluidLung
researchProduct

Focal airtrapping at expiratory high-resolution CT: comparison with pulmonary function tests

2000

This study was undertaken to determine prevalence, extent, and severity of focal airtrapping at expiratory high-resolution CT, and to compare focal airtrapping with age, gender, pulmonary function tests, and blood gas analysis. Two-hundred seventeen patients with and without pulmonary disease underwent paired inspiratory/expiratory high-resolution CT. Six scan pairs with corresponding scan levels were visually assessed for focal – not diffuse – airtrapping using a four-point scale. Pulmonary function tests and blood gas analysis were available for correlation in all patients (mean interval 5 days). Focal airtrapping with lower lung predominance was observed in 80 % of patients. Twenty-six o…

AdultLung DiseasesMalemedicine.medical_specialtyAdolescentHigh resolutionSeverity of Illness IndexPulmonary function testingHumansMedicineRadiology Nuclear Medicine and imagingLung volumesProspective StudiesAgedNeuroradiologyAged 80 and overLungbusiness.industryRespirationUltrasoundGeneral MedicineNormal lung functionMiddle AgedRespiratory Function TestsLung densitymedicine.anatomical_structureFemaleRadiologyBlood Gas AnalysisArtifactsTomography X-Ray ComputedbusinessEuropean Radiology
researchProduct

Induction of antitoxin responses in Clostridium-difficile-infected patients compared to healthy blood donors

2016

According to the literature Clostridium difficile antitoxins are present in up to 66% of humans. In a survey of ∼400 plasma samples from healthy blood donors we found that less than 6% were positive for anti-TcdA or anti-TcdB antitoxins. Using the same standard immunoassay protocol, we looked for IgG and IgA antitoxins in the blood and stool samples from 25 patients with C. difficile infection (CDI). Some patients with CDI had no antitoxin detected at all, while others had high levels of specific IgG- and IgA-antitoxins against both TcdA and TcdB in blood and IgA-anti-TcdA and -anti-TcdB antibodies in stool. Systemic responses to TcdB and mucosal responses to TcdA predominated. Among patien…

AdultMale0301 basic medicineAdolescentBacterial ToxinsClostridium difficile toxin ABlood DonorsBiologyMicrobiologyMicrobiologyYoung Adult03 medical and health sciences0302 clinical medicineImmune systemmedicineHumans030212 general & internal medicineEnterocolitis PseudomembranousAgedAntigens Bacterialmedicine.diagnostic_testClostridioides difficileCase-control studyMiddle AgedClostridium difficileAntibodies BacterialMolecular TypingTreatment Outcome030104 developmental biologyInfectious DiseasesCase-Control StudiesImmunoassayImmunologyHumoral immunitybiology.proteinFemaleAntitoxinAntibodyAnaerobe
researchProduct

A Single Nucleotide Polymorphism in the Vitamin D Receptor Gene Is Associated With Decreased Levels of the Protein and a Penetrating Pattern in Crohn…

2018

Background: Vitamin D signaling modulates inflammation through the vitamin D receptor (VDR). The synonymous single nucleotide polymorphism (SNP) rs731236, located in the VDR gene, has been associated with a higher risk of Crohn's disease (CD). We analyzed differences in VDR expression levels among CD patients who were homozygous for allelic variants in this SNP and their relevance for disease course. Methods: DNA was extracted from blood samples of CD patients, and SNP genotyping was performed by polymerase chain reaction-restriction fragment length polymorphism. Fresh blood from patients was used to isolate peripheral blood mononuclear cells (PBMCs) or to determine the expression of adhesi…

AdultMale0301 basic medicineAdolescentInterleukin-1betaSingle-nucleotide polymorphismBiologyPolymorphism Single NucleotideCalcitriol receptorPeripheral blood mononuclear cellYoung Adult03 medical and health sciences0302 clinical medicineCrohn Diseasesingle-nucleotide polymorphismsGene expressionGenotypeVitamin D and neurologyHumansvitamin D receptorImmunology and AllergySNPAlleleAllelespenetrating behaviorHomozygoteGastroenterologyMolecular biology030104 developmental biologyCase-Control Studies030220 oncology & carcinogenesisReceptors CalcitriolFemalePolymorphism Restriction Fragment LengthInflammatory Bowel Diseases
researchProduct

Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis

2017

Abstract The therapeutic mode of action of dimethyl fumarate (DMF), approved for treating patients with relapsing-remitting multiple sclerosis, is not fully understood. Recently, we and others demonstrated that Ab-independent functions of distinct B cell subsets are important in mediating multiple sclerosis (MS) relapsing disease activity. Our objective was to test whether and how DMF influences both the phenotype and functional responses of disease-implicated B cell subsets in patients with MS. High-quality PBMC were obtained from relapsing-remitting MS patients prior to and serially after initiation of DMF treatment. Multiparametric flow cytometry was used to monitor the phenotype and fun…

AdultMale0301 basic medicineDimethyl FumarateImmunologyNaive B cellB-Lymphocyte SubsetsEnzyme-Linked Immunosorbent AssayBiologyPeripheral blood mononuclear cellProinflammatory cytokineFlow cytometryYoung Adult03 medical and health scienceschemistry.chemical_compoundMultiple Sclerosis Relapsing-Remitting0302 clinical medicineIn vivomedicineHumansImmunology and AllergyB cellmedicine.diagnostic_testDimethyl fumarateMultiple sclerosisMiddle AgedFlow Cytometrymedicine.disease030104 developmental biologymedicine.anatomical_structurechemistryImmunologyCancer researchFemaleImmunosuppressive Agents030217 neurology & neurosurgeryThe Journal of Immunology
researchProduct